Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      APPROVED_FOR_MARKETING
      Long Term Treatment With L-DOPS
      Description

      This study is designed to supply L-DOPS (droxidopa) on a long term basis to patients with a genetic form of profound orthostatic hypotension, most commonly DBH deficiency. It also allows us to collect medical history information on this small population of patients that would allow us to determine if there are any complications from this type of treatment.

      Conditions
      Dopamine Beta Hydroxylase (DBH) Deficiency
      Talk to us
      TERMINATED
      A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
      Description

      Evaluate the clinical efficacy and safety of droxidopa versus placebo over a 17 week (maximum) treatment period in patients with symptomatic NOH.

      Conditions
      Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems AtrophyPure Autonomic FailureDopamine Beta Hydroxylase Deficiency
      Talk to us